Latest Insider Transactions at Core Scientific, Inc. (CORZ)
This section provides a real-time view of insider transactions for Core Scientific, Inc. (CORZ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Core Scientific, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Core Scientific, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2024
|
Todd M Duchene |
SELL
Open market or private sale
|
Direct |
25,000
-1.48%
|
$425,000
$17.1 P/Share
|
|
Nov 11
2024
|
Yadin Rozov |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
195,000
+30.22%
|
$0
$0.01 P/Share
|
|
Sep 13
2024
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct |
2,240
+0.74%
|
$24,640
$11.05 P/Share
|
|
Sep 11
2024
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct |
2,100
+0.7%
|
$21,000
$10.1 P/Share
|
|
Sep 10
2024
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct |
2,100
+0.71%
|
$18,900
$9.9 P/Share
|
|
Sep 09
2024
|
Eric Stanton Weiss |
BUY
Open market or private purchase
|
Direct |
5,000
+2.5%
|
$45,000
$9.21 P/Share
|
|
Sep 05
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
318,613
+41.95%
|
-
|
|
Sep 04
2024
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct |
7,800
+2.59%
|
$70,200
$9.28 P/Share
|
|
Sep 03
2024
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct |
5,021
+1.73%
|
$45,189
$9.68 P/Share
|
|
Aug 30
2024
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct |
1,500
+0.53%
|
$13,500
$9.95 P/Share
|
|
Aug 28
2024
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct |
4,000
+1.41%
|
$36,000
$9.7 P/Share
|
|
Aug 20
2024
|
Jordan Levy |
BUY
Open market or private purchase
|
Direct |
48,700
+17.86%
|
$487,000
$10.2 P/Share
|
|
Aug 16
2024
|
Adam Taylor Sullivan Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
95,303
+2.29%
|
$0
$0.01 P/Share
|
|
Aug 16
2024
|
Todd M Duchene |
SELL
Open market or private sale
|
Direct |
11,582
-0.68%
|
$104,238
$9.41 P/Share
|
|
Aug 16
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,752
-6.68%
|
$78,768
$9.41 P/Share
|
|
Jul 19
2024
|
Todd M Duchene |
BUY
Grant, award, or other acquisition
|
Direct |
1,338,179
+20.18%
|
-
|
|
Jun 25
2024
|
Todd M Duchene |
SELL
Open market or private sale
|
Direct |
7,321
-1.99%
|
$65,889
$9.39 P/Share
|
|
Jun 14
2024
|
Todd M Duchene |
SELL
Open market or private sale
|
Direct |
26,230
-6.67%
|
$236,070
$9.9 P/Share
|
|
Jun 14
2024
|
Adam Taylor Sullivan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,823,363
+23.55%
|
-
|
|
Jun 13
2024
|
Todd M Duchene |
SELL
Open market or private sale
|
Direct |
3,770
-0.95%
|
$33,930
$9.99 P/Share
|
|
May 27
2024
|
Todd A Becker |
BUY
Grant, award, or other acquisition
|
Direct |
175,239
+23.06%
|
-
|
|
May 27
2024
|
Jordan Levy |
BUY
Grant, award, or other acquisition
|
Direct |
175,239
+35.71%
|
-
|
|
May 27
2024
|
Jarrod M Patten |
BUY
Grant, award, or other acquisition
|
Direct |
175,239
+25.35%
|
-
|
|
May 27
2024
|
Jeffrey David Booth |
BUY
Grant, award, or other acquisition
|
Direct |
175,239
+35.71%
|
-
|
|
May 27
2024
|
Yadin Rozov |
BUY
Grant, award, or other acquisition
|
Direct |
175,239
+26.91%
|
-
|
|
May 27
2024
|
Eric Stanton Weiss |
BUY
Grant, award, or other acquisition
|
Direct |
175,239
+33.65%
|
-
|
|
May 13
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,261
-3.15%
|
$12,783
$3.66 P/Share
|
|
Mar 15
2024
|
Todd A Becker |
BUY
Open market or private purchase
|
Direct |
130,000
+49.2%
|
$390,000
$3.16 P/Share
|
|
Mar 15
2024
|
Jarrod M Patten |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$300,000
$3.32 P/Share
|
|
Mar 15
2024
|
Yadin Rozov |
BUY
Open market or private purchase
|
Direct |
80,000
+50.0%
|
$240,000
$3.07 P/Share
|
|
Mar 15
2024
|
Adam Taylor Sullivan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
65,300
+41.06%
|
$195,900
$3.06 P/Share
|
|
Mar 15
2024
|
Eric Stanton Weiss |
BUY
Open market or private purchase
|
Direct |
15,000
+50.0%
|
$45,000
$3.03 P/Share
|
|
Feb 22
2024
|
Todd M Duchene |
SELL
Payment of exercise price or tax liability
|
Direct |
24,153
-5.73%
|
$72,459
$3.23 P/Share
|
|
Feb 22
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,617
-10.94%
|
$49,851
$3.23 P/Share
|
|
Jan 23
2024
|
Darin Feinstein Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,294,195
+50.0%
|
-
|
|
Jan 23
2024
|
Darin Feinstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,337,169
+26.33%
|
-
|
|
Jan 23
2024
|
Darin Feinstein Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,294,195
-100.0%
|
-
|
|
Jan 23
2024
|
Darin Feinstein Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,483,592
-100.0%
|
-
|
|
Jan 23
2024
|
Matt Minnis Director |
BUY
Grant, award, or other acquisition
|
Indirect |
29,453,080
+25.57%
|
-
|
|
Jan 23
2024
|
Matt Minnis Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
29,111,651
-100.0%
|
-
|
|
Jan 23
2024
|
Jarvis V. Hollingsworth |
BUY
Grant, award, or other acquisition
|
Direct |
1,211,956
+50.0%
|
-
|
|
Jan 23
2024
|
Jarvis V. Hollingsworth |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,211,956
-100.0%
|
-
|
|
Jan 23
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,518,472
+50.0%
|
-
|
|
Jan 23
2024
|
Denise Marie Brucia Sterling Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,518,472
-100.0%
|
-
|
|
Jan 23
2024
|
Adam Taylor Sullivan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,453
+50.0%
|
-
|
|
Jan 23
2024
|
Michael J Levitt Director |
BUY
Grant, award, or other acquisition
|
Indirect |
21,154,604
+30.81%
|
-
|
|
Jan 23
2024
|
Michael J Levitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,179,833
+25.21%
|
-
|
|
Jan 23
2024
|
Michael J Levitt Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
20,244,350
-100.0%
|
-
|
|
Jan 23
2024
|
Michael J Levitt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,094,478
-100.0%
|
-
|
|
Jan 23
2024
|
Dr Kneeland Youngblood |
BUY
Grant, award, or other acquisition
|
Direct |
400,038
+50.0%
|
-
|